| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Crispr Therapeutics AG (CRSP) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. CRSP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 255.5K | $13.89M | - | |
| Dir | 22.0K | $1.20M | - | |
| CFO | 19.5K | $1.06M | - | |
| Other | 19.4K | $1.05M | -3,786 | |
| Other | 17.0K | $924.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2017 | Woiwode Thomas | Director | Sell | 3,059 | $20.29 | $62,070.47 | -38.2% | |
| Dec 15, 2017 | Dylan-Hyde Tyler | Chief Legal Officer | Sell | 15,000 | $18.90 | $283,495.50 | -10.3% | |
| Nov 27, 2017 | Woiwode Thomas | Director | Sell | 1,900 | $20.21 | $38,405.85 | -10.5% | |
| Nov 27, 2017 | Bolzon Bradley J Phd75 | Director | Sell | 1,707 | $20.21 | $34,498.44 | -1.6% | |
| Sep 5, 2017 | Novak Rodger75 | Chief Executive Officer | Sale+OE | 18,470 | $20.76 | $383,393.19 | -0.8% | |
| Aug 30, 2017 | Novak Rodger75 | Chief Executive Officer | Sale+OE | 75,795 | $20.25 | $1,534,869.13 | -3.1% | |
| Aug 30, 2017 | Kulkarni Samarth68 | Chief Business Officer | Sell | 27,154 | $20.08 | $545,161.54 | -11.1% | |
| Aug 28, 2017 | Emster Kurt Von62 | Director | Sell | 88,011 | $19.79 | $1,741,737.69 | -4.3% | |
| Aug 25, 2017 | Emster Kurt Von62 | Director | Sell | 22,781 | $19.42 | $442,403.40 | -0.6% | |
| Aug 23, 2017 | Emster Kurt Von62 | Director | Sell | 17,989 | $18.53 | $333,336.17 | -0.4% |